Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1736861000001115 | Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1736871000001113 | Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
79029401000001110 | Adempas 2mg tablets (Bayer Plc) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
79029501000001114 | Adempas 2mg tablets (Bayer Plc) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
96162101000001118 | Adempas 2mg tablets (Merck Sharp & Dohme Ltd) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets | Has AMP | True | Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) | Inferred relationship | Existential restriction modifier | |
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 84 tablet 4 x 21 tablets | Has AMP | True | Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets